Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Excellent response to bortezomib in a patient with widespread ulcerative pyoderma gangrenosum accompanied by pulmonary involvement and IgA monoclonal gammopathy.

  • Authors : Bostan E; Department of Dermatology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.; Günaydın SD

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Bortezomib/Bortezomib/Bortezomib/*therapeutic use ; Immunoglobulin A/Immunoglobulin A/Immunoglobulin A/*blood

  • Source: International wound journal [Int Wound J] 2019 Aug; Vol. 16 (4), pp. 1052-1054. Date of Electronic Publication: 2019 May 02.Publisher: Blackwell Pub Country of Publication: England NLM ID: 101230907 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.

Subjects: Bortezomib/Bortezomib/Bortezomib/*therapeutic use ; Dexamethasone/Dexamethasone/Dexamethasone/*therapeutic use ; Multiple Myeloma/Multiple Myeloma/Multiple Myeloma/*drug therapy

  • Source: International wound journal [Int Wound J] 2017 Dec; Vol. 14 (6), pp. 1382-1384. Date of Electronic Publication: 2017 Mar 29.Publisher: Blackwell Pub Country of Publication: England NLM ID: 101230907 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-2 of  2 results for ""Bortezomib therapeutic use""